Ravi Salgia

Trials

Studies that name Ravi Salgia as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:55 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT07288034 · Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial

  City of Hope Medical Center · recruiting · Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 · principal investigator
• Ph1
  NCT06249282 · Carfilzomib in Combination With Sotorasib for the Treatment of Patients With KRAS G12C Mutated Advanced or Metastatic Non-small Cell Lung Cancer

  City of Hope Medical Center · recruiting · Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 · principal investigator
• Ph1
  NCT05163028 · A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations

  HUYABIO International, LLC. · active not recruiting · Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer · principal investigator
• Ph1
  NCT04560972 · LB-100, Carboplatin, Etoposide, and Atezolizumab for the Treatment of Untreated Extensive-Stage Small Cell Lung Cancer

  City of Hope Medical Center · active not recruiting · Extensive Stage Lung Small Cell Carcinoma · principal investigator
• Ph1
  NCT04158635 · Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

  City of Hope Medical Center · suspended · Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8, Unresectable Pancreatic Carcinoma · principal investigator
• Ph2
  NCT03402880 · ALCMI-005: Pembrolizumab and Epacadostat in Treating Patients With Extensive Stage Small Cell Lung Cancer

  City of Hope Medical Center · withdrawn · Extensive Stage Small Cell Lung Carcinoma · principal investigator
• Ph2
  NCT01803269 · Topotecan Hydrochloride or Cyclodextrin-Based Polymer-Camptothecin CRLX101 in Treating Patients With Recurrent Small Cell Lung Cancer

  University of Chicago · terminated · Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer · principal investigator
• N/A
  NCT00900328 · Study of Tumor Samples From Patients With Lung Cancer

  Alliance for Clinical Trials in Oncology · completed · Lung Cancer · study chair
• Ph2
  NCT00042978 · Carboplatin and Etoposide With or Without Oblimersen Sodium in Treating Patients With Extensive Stage Small Cell Lung Cancer

  National Cancer Institute (NCI) · completed · Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-11 22:55 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 5 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

• Hepatocyte Growth Factor/c-Met Invovement in Lung EC Barrier Regulation
  P01HL058064 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · fiscal years 2008 to 2012 · $300,642 awarded in 2012
  Same name and institution; not confirmed by an ID
• Role of c-Met in SCLC and Potential for Novel Therapy
  R01CA100750 · NCI · UNIVERSITY OF CHICAGO · fiscal years 2004 to 2012 · $241,067 awarded in 2012
  Same name and institution; not confirmed by an ID
• Role of Paxillin in Lung Cancer
  R01CA129501 · NCI · UNIVERSITY OF CHICAGO · fiscal years 2008 to 2012 · $318,450 awarded in 2012
  Same name and institution; not confirmed by an ID
• Studies of a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC)
  R01CA125541 · NCI · UNIVERSITY OF CHICAGO · fiscal years 2007 to 2011 · $254,610 awarded in 2011
  Same name and institution; not confirmed by an ID
• Novel Targeted Therapy in Pancreatic Cancer
  R21CA140003 · NCI · UNIVERSITY OF CHICAGO · fiscal years 2009 to 2010 · $205,920 awarded in 2010
  Same name and institution; not confirmed by an ID

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Leadership, Planning and Evaluation
  P30CA033572 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI JOHN D. CARPTEN · fiscal years 2011 to 2026
  Named on NCT07288034, NCT06249282, NCT04560972
• Alliance for Clinical Trials in Oncology Member Site Core
  U10CA180821 · NCI · ALLIANCE NCTN FOUNDATION · PI Evanthia Galanis · fiscal years 2014 to 2026
  Named on NCT00900328
• Cancer and Leukemia Group B
  U10CA031946 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI Monica M Bertagnolli · fiscal years 2011 to 2013
  Named on NCT00042978